The data suggested that the overexpression of PGK1 was strongly associated with a poor overall survival and a progression-free survival in lung cancer, especially in the adenocarcinoma subtype, which has been thought to be the most common type of lung cancer clinically (Fig. 3C–F). This evidence concerns the gene PGK1 and lung carcinoma.